The comparative pharmacology of cyclophosphamide and ifosfamide
Colvin, M.
Seminars in Oncology 9(4 Suppl 1: 2-7
1982
ISSN/ISBN: 0093-7754 PMID: 6761865 Document Number: 186353
Document emailed within 1 workday
Related Documents
Ruzicka, J.A.; Ruenitz, P.C. 1992: Cytochrome P-450-mediated N-dechloroethylation of cyclophosphamide and ifosfamide in the rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(5): 770-772Gad-el-Mawla, N.; Ziegler, J.L.; Hamza, R.; Elserafi, M.; Khaled, H. 1984: Phase II chemotherapy trials of 5-FU, cyclophosphamide, ifosfamide, and vincristine in carcinoma of the bilharzial bladder Cancer Treatment Reports 68(2): 419-421
Brock, N.; Stekar, J.; Pohl, J.; Niemeyer, U.; Scheffler, G. 1979: Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide Arzneimittel-Forschung 29(4): 659-661
Norpoth, K.; Addicks, H.W.; Witting, U.; Mŭller, G.; Raidt, H. 1975: Quantitative determination of cyclophosphamide, ifosfamide, and trofosfamide and their stable metabolites on TLC-plates with the aid of 4-pyridine-aldehyde-2-benzothiazolyl-hydrazone (PBH) Arzneimittel-Forschung 25(9): 1331-1336
Chen, L.; Waxman, D.J.; Chen, D.; Kufe, D.W. 1996: Sensitization of human breast cancer cells to cyclophosphamide and ifosfamide by transfer of a liver cytochrome P450 gene Cancer Research 56(6): 1331-1340
Bezwoda, W.R.; Rastogi, R.B. 1994: A randomized comparative study of cyclophosphamide, vincristine, doxorubicin, and prednisolone and cyclophosphamide, vincristine, mitoxantrone, and prednisolone regimens in the treatment of intermediate- and high-grade lymphoma with 8 years' follow-up Seminars in Hematology 31(2 Suppl 3: 3
Kasai, I.; Kumano, K.; Iwamura, M.; Yoshida, K.; Mashimo, S.; Endo, T.; Sakai, T.; Koshiba, K.; Iitaka, K.; Uchida, H. 1989: Comparative analysis of DST alone and DST with intermittent coverage by cyclophosphamide Transplantation Proceedings 21(1 Pt 2): 1837-1838
Flores, M.; Gudiño Pérez, R.; Ríos Prado, R.; Almedia Arvizu, V.M.; Castrejón Vázquez, M.I.; Ocampo, A.A. 2001: Comparative study of the treatment of autoimmune uveitis with prednisone and with cyclophosphamide and azathioprine Revista Alergia Mexico 48(3): 75-79
Asselin, B.L. 1999: The three asparaginases. Comparative pharmacology and optimal use in childhood leukemia Advances in Experimental Medicine and Biology 457: 621-629
Walz, D.T.; DiMartino, M.J.; Griswold, D.E. 1982: Comparative pharmacology and biological effects of different gold compounds Journal of Rheumatology. Suppl 8: 54-60
Godfraind, T. 1989: Comparative pharmacology of cardiac and vascular tissues in heart failure Journal of Cardiovascular Pharmacology 14(Suppl 8): S1-20
Suling, W.J.; Struck, R.F.; Woolley, C.W.; Shannon, W.M. 1978: Comparative disposition of phosphoramide mustard and other cyclophosphamide metabolites in the mouse using the Salmonella/mutagenesis assay Cancer Treatment Reports 62(9): 1321-1328
Greco, G.; Tota, B. 1981: The ventricular myocardium of fish: aspects of comparative morphology physiology and pharmacology. II) Coronary circulation Bollettino della Societa Italiana di Biologia Sperimentale 57(20): 2060-2066
Otterness, I.G.; Chang, Y.H. 1976: Comparative study of cyclophosphamide, 6-mercaptopurine, azathiopurine and methotrexate. Relative effects on the humoral and the cellular immune response in the mouse Clinical and Experimental Immunology 26(2): 346-354
Gries, J.; Schuster, J.; Giertz, H.; Lehmann, H.D.; Lenke, D.; Worstmann, W. 1981: Pharmacology of amezinium, a novel antihypotensive drug. I. Comparative studies of the effect on blood pressure and heart rate Arzneimittel-Forschung 31(9a): 1533-1543
Vapattanawong, P. 2006: A comparative study on hematological effects of carboplatin plus cyclophosphamide and carboplatin plus paclitaxel chemotherapy for the first line treatment of epithelial ovarian cancer Journal of the Medical Association of Thailand 89(9): 1357-1361
Trouillas, P.; Neuschwander, P.; Nighoghossian, N.; Adeleine, P.; Tremisi, P. 1989: Intensive immunosuppression in progressive multiple sclerosis. An open study comparing 3 groups: cyclophosphamide, cyclophosphamide-plasmapheresis and control subjects. Results after 3 years Revue Neurologique (Paris) 145(5): 369-377
Bend, J.R.; Weber, L.J. 1980: Aquatic animals as models in biomedical research/comparative pharmacology in aquatic species Federation Proceedings 39(14): 3183
Duchêne-Marullaz, P. 1977: Pharmacology, clinical pharmacology and therapeutic effects of Royat's thermal gas Semaine des Hopitaux. Therapeutique 53(7-8): 361-362
West, R.J.; Zweig, S.F. 1997: Meta-analysis of chemotherapy regimens for ovarian carcinoma: a reassessment of cisplatin, cyclophosphamide and doxorubicin versus cisplatin and cyclophosphamide European Journal of Gynaecological Oncology 18(5): 343-348